The large tumor antigen: A " Swiss Army knife" protein possessing the functions required for the polyomavirus life cycle

Antiviral Research

Volumn 97, Issue 2, 2013, Pages 122-136

  Topalis, D ^a   Andrei, G ^a   Snoeck, R ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Large T antigen; Merkel cell polyomavirus; Oncoproteins; Papillomavirus; Polyomavirus; Replicative helicase

Indexed keywords

HEAT SHOCK PROTEIN 70; PROTEIN E6; PROTEIN P53; TRANSCRIPTION FACTOR E2F; VIRUS DNA; VIRUS LARGE T ANTIGEN;

ACETYLATION; ALTERNATIVE RNA SPLICING; ANTIPROLIFERATIVE ACTIVITY; ANTIVIRAL ACTIVITY; BOVINE PAPILLOMAVIRUS TYPE 1; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL TRANSFORMATION; DNA REPAIR; GENOME ANALYSIS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; HYDROGEN BOND; IC 50; LIFE CYCLE; MERKEL CELL POLYOMAVIRUS; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; REVIEW; SEQUENCE ALIGNMENT; STEREOSPECIFICITY; UBIQUITINATION; VIRUS GENOME; VIRUS LIFE CYCLE; VIRUS REPLICATION;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL TRANSFORMATION, VIRAL; HUMANS; ONCOGENE PROTEINS; PAPILLOMAVIRIDAE; POLYOMAVIRUS; VIRULENCE FACTORS; VIRUS REPLICATION;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE; POLYOMAVIRUS;

EID: 84871862472     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2012.11.007     Document Type: Review

References (200)

1. Abbate E.A., Berger J.M., Botchan M.R. The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2. Genes Dev. 2004, 18:1981-1996.
2. Abend J.R., Jiang M., Imperiale M.J. BK virus and human cancer: innocent until proven guilty. Semin. Cancer Biol. 2009, 19:252-260.
3. Abend J.R., Joseph A.E., Das D., Campbell-Cecen D.B., Imperiale M.J. A truncated T antigen expressed from an alternatively spliced BK virus early mRNA. J. Gen. Virol. 2009, 90:1238-1245.
4. Allander T., Andreasson K., Gupta S., Bjerkner A., Bogdanovic G., Persson M.A., Dalianis T., Ramqvist T., Andersson B. Identification of a third human polyomavirus. J. Virol. 2007, 81:4130-4136.
5. Andrei G., Snoeck R., Vandeputte M., De Clercq E. Activities of various compounds against murine and primate polyomaviruses. Antimicrob. Agents Chemother. 1997, 41:587-593.
6. Arroyo J.D., Hahn W.C. Involvement of PP2A in viral and cellular transformation. Oncogene 2005, 24:7746-7755.
7. Bag A.K., Cure J.K., Chapman P.R., Roberson G.H., Shah R. JC virus infection of the brain. AJNR Am. J. Neuroradiol. 2010, 31:1564-1576.
8. Barzon L., Squarzon L., Militello V., Trevisan M., Palu G. Human KI and WU polyomavirus infection in immunocompromised subjects. J. Clin. Virol. 2009, 45:370.
9. Berger J.R. The clinical features of PML. Cleve. Clin. J. Med. 2011, 78(2):S8-S12.
10. Berger J.R., Houff S. Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab. Neurol. Res. 2006, 28:299-305.
11. Berk A.J. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 2005, 24:7673-7685.
12. Bernhoff E., Gutteberg T.J., Sandvik K., Hirsch H.H., Rinaldo C.H. Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression. Am. J. Transplant. 2008, 8:1413-1422.
13. Bernhoff E., Tylden G.D., Kjerpeseth L.J., Gutteberg T.J., Hirsch H.H., Rinaldo C.H. Leflunomide inhibition of BK virus replication in renal tubular epithelial cells. J. Virol. 2010, 84:2150-2156.
14. Bochkareva E., Martynowski D., Seitova A., Bochkarev A. Structure of the origin-binding domain of simian virus 40 large T antigen bound to DNA. EMBO J. 2006, 25:5961-5969.
15. Bohl D.L., Brennan D.C. BK virus nephropathy and kidney transplantation. Clin. J. Am. Soc. Nephrol. 2007, 2(Suppl. 1):S36-S46.
16. Bollag B., Prins C., Snyder E.L., Frisque R.J. Purified JC virus T and T' proteins differentially interact with the retinoblastoma family of tumor suppressor proteins. Virology 2000, 274:165-178.
17. Bollag B., Kilpatrick L.H., Tyagarajan S.K., Tevethia M.J., Frisque R.J. JC virus T'135, T'136 and T'165 proteins interact with cellular p107 and p130 in vivo and influence viral transformation potential. J. Neurovirol. 2006, 12:428-442.
18. Borger D.R., DeCaprio J.A. Targeting of p300/CREB binding protein coactivators by simian virus 40 is mediated through p53. J. Virol. 2006, 80:4292-4303.
19. Borowiec J.A., Hurwitz J. ATP stimulates the binding of simian virus 40 (SV40) large tumor antigen to the SV40 origin of replication. Proc. Natl. Acad. Sci. USA 1988, 85:64-68.
20. Boyer S.N., Wazer D.E., Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 1996, 56:4620-4624.
21. Brade L., Vogl W., Gissman L., zur Hausen H. Propagation of B-lymphotropic papovavirus (LPV) in human B-lymphoma cells and characterization of its DNA. Virology 1981, 114:228-235.
22. Buck C.B., Phan G.Q., Raiji M.T., Murphy P.M., McDermott D.H., McBride A.A. Complete genome sequence of a tenth human polyomavirus. J. Virol. 2012, 86:10887.
23. Burns A., Arnason T., Fraser R., Murray S., Walsh N. Keratotic " spiny" papules in an immunosuppressed child. Trichodysplasia spinulosa (TS). Arch. Dermatol. 2011, 147:1215-1220.
24. Campbell K.S., Mullane K.P., Aksoy I.A., Stubdal H., Zalvide J., Pipas J.M., Silver P.A., Roberts T.M., Schaffhausen B.S., DeCaprio J.A. DnaJ/hsp40 chaperone domain of SV40 large T antigen promotes efficient viral DNA replication. Genes Dev. 1997, 11:1098-1110.
25. Chen T., Mattila P.S., Jartti T., Ruuskanen O., Soderlund-Venermo M., Hedman K. Seroepidemiology of the newly found Trichodysplasia spinulosa-associated polyomavirus. J. Infect. Dis. 2011, 204:1523-1526.
26. Chiang C.M., Ustav M., Stenlund A., Ho T.F., Broker T.R., Chow L.T. Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc. Natl. Acad. Sci. USA 1992, 89:5799-5803.
27. Chipuk J.E., Kuwana T., Bouchier-Hayes L., Droin N.M., Newmeyer D.D., Schuler M., Green D.R. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004, 303:1010-1014.
28. Cho U.S., Morrone S., Sablina A.A., Arroyo J.D., Hahn W.C., Xu W. Structural basis of PP2A inhibition by small t antigen. PLoS. Biol. 2007, 5:e202.
29. Clark R., Lane D.P., Tjian R. Use of monoclonal antibodies as probes of simian virus 40 T antigen ATPase activity. J. Biol. Chem. 1981, 256:11854-11858.
30. Clark R., Peden K., Pipas J.M., Nathans D., Tjian R. Biochemical activities of T-antigen proteins encoded by simian virus 40 A gene deletion mutants. Mol. Cell Biol. 1983, 3:220-228.
31. Clertant P., Gaudray P., May E., Cuzin F. The nucleotide binding site detected by affinity labeling in the large T proteins of polyoma and SV40 viruses is distinct from their ATPase catalytic site. J. Biol. Chem. 1984, 259:15196-15203.
32. Crandall K.A., Perez-Losada M., Christensen R.G., McClellan D.A., Viscidi R.P. Phylogenomics and molecular evolution of polyomaviruses. Adv. Exp. Med. Biol. 2006, 577:46-59.
33. Dalrymple S.A., Beemon K.L. BK virus T antigens induce kidney carcinomas and thymoproliferative disorders in transgenic mice. J. Virol. 1990, 64:1182-1191.
34. de Biase D., Ragazzi M., Asioli S., Eusebi V. Extracutaneous Merkel cell carcinomas harbor polyomavirus DNA. Hum. Pathol. 2012, 43:980-985.
35. De Maio A. Heat shock proteins: facts, thoughts, and dreams. Shock 1999, 11:1-12.
36. de Souza R.F., Iyer L.M., Aravind L. Diversity and evolution of chromatin proteins encoded by DNA viruses. Biochim. Biophys. Acta 2010, 1799:302-318.
37. Dean F.B., Borowiec J.A., Ishimi Y., Deb S., Tegtmeyer P., Hurwitz J. Simian virus 40 large tumor antigen requires three core replication origin domains for DNA unwinding and replication in vitro. Proc. Natl. Acad. Sci. USA 1987, 84:8267-8271.
38. Deb S.P., Tegtmeyer P. ATP enhances the binding of simian virus 40 large T antigen to the origin of replication. J. Virol. 1987, 61:3649-3654.
39. Del Valle L., Pina-Oviedo S., Perez-Liz G., Augelli B.J., Azizi S.A., Khalili K., Gordon J., Krynska B. Bone marrow-derived mesenchymal stem cells undergo JCV T-antigen mediated transformation and generate tumors with neuroectodermal characteristics. Cancer Biol. Ther. 2010, 9:286-294.
40. Delbue S., Tremolada S., Elia F., Carloni C., Amico S., Tavazzi E., Marchioni E., Novati S., Maserati R., Ferrante P. Lymphotropic polyomavirus is detected in peripheral blood from immunocompromised and healthy subjects. J. Clin. Virol. 2010, 47:156-160.
41. Dorries K., Vogel E., Gunther S., Czub S. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 1994, 198:59-70.
42. Dropulic L.K., Jones R.J. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant. 2008, 41:11-18.
43. Dyson N. PRB, p107 and the regulation of the E2F transcription factor. J. Cell Sci. (Suppl) 1994, 18:81-87.
44. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 1998, 12:2245-2262.
45. Dyson N., Buchkovich K., Whyte P., Harlow E. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 1989, 58:249-255.
46. Dyson N., Howley P.M., Munger K., Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989, 243:934-937.
47. Enemark E.J., Chen G., Vaughn D.E., Stenlund A., Joshua-Tor L. Crystal structure of the DNA binding domain of the replication initiation protein E1 from papillomavirus. Mol. Cell 2000, 6:149-158.
48. Enemark E.J., Stenlund A., Joshua-Tor L. Crystal structures of two intermediates in the assembly of the papillomavirus replication initiation complex. EMBO J. 2002, 21:1487-1496.
49. Erovic, B.M., Al, Habeeb A., Harris, L., Goldstein, D.P., Ghazarian, D., Irish, J.C., 2012. Significant overexpression of the Merkel cell polyomavirus (MCPyV) large T antigen in Merkel cell carcinoma. Head Neck, doi:10.1002/hed.22942.
50. Falcone V., Panning M., Strahm B., Vraetz T., Bierbaum S., Neumann-Haefelin D., Huzly D. Prolonged KI Polyomavirus infection in immunodeficient child. Emerg. Infect. Dis. 2012, 18:706-708.
51. Feng H., Shuda M., Chang Y., Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319:1096-1100.
52. Feng H., Kwun H.J., Liu X., Gjoerup O., Stolz D.B., Chang Y., Moore P.S. Cellular and viral factors regulating Merkel cell polyomavirus replication. PLoS One 2011, 6:e22468.
53. Ferber D. Public health. Creeping consensus on SV40 and polio vaccine. Science 2002, 298:725-727.
54. Ferreon J.C., Martinez-Yamout M.A., Dyson H.J., Wright P.E. Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein. Proc. Natl. Acad. Sci. USA 2009, 106:13260-13265.
55. Fioriti D., Degener A.M., Mischitelli M., Videtta M., Arancio A., Sica S., Sora F., Pietropaolo V. BKV infection and hemorrhagic cystitis after allogeneic bone marrow transplant. Int. J. Immunopathol. Pharmacol. 2005, 18:309-316.
56. Fischer M.K., Kao G.F., Nguyen H.P., Drachenberg C.B., Rady P.L., Tyring S.K., Gaspari A.A. Specific detection of Trichodysplasia spinulosa-associated polyomavirus DNA in skin and renal allograft tissues in a patient with Trichodysplasia spinulosa. Arch. Dermatol. 2012, 148:726-733.
57. Franks R.R., Rencic A., Gordon J., Zoltick P.W., Curtis M., Knobler R.L., Khalili K. Formation of undifferentiated mesenteric tumors in transgenic mice expressing human neurotropic polymavirus early protein. Oncogene 1996, 12:2573-2578.
58. Furuno A., Miyamura T., Yoshiike K. Monkey B-lymphotropic papovavirus DNA: nucleotide sequence of the region around the origin of replication. J. Virol. 1984, 50:451-456.
59. Gai D., Li D., Finkielstein C.V., Ott R.D., Taneja P., Fanning E., Chen X.S. Insights into the oligomeric states, conformational changes, and helicase activities of SV40 large tumor antigen. J. Biol. Chem. 2004, 279:38952-38959.
60. Gardner S.D., Field A.M., Coleman D.V., Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971, 1:1253-1257.
61. Gaynor A.M., Nissen M.D., Whiley D.M., Mackay I.M., Lambert S.B., Wu G., Brennan D.C., Storch G.A., Sloots T.P., Wang D. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS. Pathog. 2007, 3:e64.
62. Goldman N., Brown M., Khoury G. Modification of SV40 T antigen by poly ADP-ribosylation. Cell 1981, 24:567-572.
63. Gordon J., Del Valle.L., Otte J., Khalili K. Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice. Oncogene 2000, 19:4840-4846.
64. Gosert R., Rinaldo C.H., Wernli M., Major E.O., Hirsch H.H. CMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human brain progenitor-derived astrocytes. Antimicrob. Agents Chemother. 2011, 55:2129-2136.
65. Greenleaf W.B., Shen J., Gai D., Chen X.S. Systematic study of the functions for the residues around the nucleotide pocket in simian virus 40 AAA+ hexameric helicase. J. Virol. 2008, 82:6017-6023.
66. Hahn W.C., Dessain S.K., Brooks M.W., King J.E., Elenbaas B., Sabatini D.M., DeCaprio J.A., Weinberg R.A. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol. Cell Biol. 2002, 22:2111-2123.
67. Haitz K.A., Rady P.L., Nguyen H.P., He Q., Prieto V.G., Tyring S.K., Ciurea A.M. Merkel cell polyomavirus DNA detection in a patient with Merkel cell carcinoma and multiple other skin cancers. Int. J. Dermatol. 2012, 51:442-444.
68. Han T.H., Chung J.Y., Koo J.W., Kim S.W., Hwang E.S. WU polyomavirus in children with acute lower respiratory tract infections, South Korea. Emerg. Infect. Dis. 2007, 13:1766-1768.
69. Harrison C.J., Meinke G., Kwun H.J., Rogalin H., Phelan P.J., Bullock P.A., Chang Y., Moore P.S., Bohm A. Asymmetric assembly of Merkel cell polyomavirus large T-antigen origin binding domains at the viral origin. J. Mol. Biol. 2011, 409:529-542.
70. Haycox C.L., Kim S., Fleckman P., Smith L.T., Piepkorn M., Sundberg J.P., Howell D.N., Miller S.E. Trichodysplasia spinulosa-a newly described folliculocentric viral infection in an immunocompromised host. J. Investig. Dermatol. Symp. Proc. 1999, 4:268-271.
71. Helt A.M., Galloway D.A. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes. J. Virol. 2001, 75:6737-6747.
72. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. P53 mutations in human cancers. Science 1991, 253:49-53.
73. Hormozdi D.J., Arens M.Q., Le B.M., Buller R.S., Agapov E., Storch G.A. KI polyomavirus detected in respiratory tract specimens from patients in St. Louis. Missouri. Pediatr. Infect. Dis. J. 2010, 29:329-333.
74. Houben R., Shuda M., Weinkam R., Schrama D., Feng H., Chang Y., Moore P.S., Becker J.C. Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J. Virol. 2010, 84:7064-7072.
75. Houben R., Adam C., Baeurle A., Hesbacher S., Grimm J., Angermeyer S., Henzel K., Hauser S., Elling R., Brocker E.B., Gaubatz S., Becker J.C., Schrama D. An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells. Int. J. Cancer. 2011, 130:847-856.
76. Howe A.K., Gaillard S., Bennett J.S., Rundell K. Cell cycle progression in monkey cells expressing simian virus 40 small t antigen from adenovirus vectors. J. Virol. 1998, 72:9637-9644.
77. Hume A.J., Kalejta R.F. Regulation of the retinoblastoma proteins by the human herpesviruses. Cell Div. 2009, 4:1.
78. Janssens V., Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 2001, 353:417-439.
79. Kaibuchi-Noda K., Yokota K., Matsumoto T., Sawada M., Sakakibara A., Kono M., Tomita Y., Watanabe D., Fukumoto H., Katano H., Akiyama M. Detection of Merkel cell polyomavirus in cutaneous squamous cell carcinoma before occurrence of Merkel cell carcinoma. J. Am. Acad. Dermatol. 2011, 65:e152-e154.
80. Kastan M.B. DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture. Mol. Cancer Res. 2008, 6:517-524.
81. Kazem S., van der Meijden E., Kooijman S., Rosenberg A.S., Hughey L.C., Browning J.C., Sadler G., Busam K., Pope E., Benoit T., Fleckman P., de Vries E., Eekhof J.A., Feltkamp M.C. Trichodysplasia spinulosa is characterized by active polyomavirus infection. J. Clin. Virol. 2011, 53:225-230.
82. Kean J.M., Rao S., Wang M., Garcea R.L. Seroepidemiology of human polyomaviruses. PLoS. Pathog. 2009, 5:e1000363.
83. Khalili K., White M.K. Human demyelinating disease and the polyomavirus JCV. Mult. Scler. 2006, 12:133-142.
84. Khalili K., White M.K., Lublin F., Ferrante P., Berger J.R. Reactivation of JC virus and development of PML in patients with multiple sclerosis. Neurology 2007, 68:985-990.
85. Kierstead T.D., Tevethia M.J. Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblasts by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations. J. Virol. 1993, 67:1817-1829.
86. Kim H.Y., Ahn B.Y., Cho Y. Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen. EMBO J. 2001, 20:295-304.
87. Klockmann U., Deppert W. Acylated simian virus 40 large T-antigen: a new subclass associated with a detergent-resistant lamina of the plasma membrane. EMBO J. 1983, 2:1151-1157.
88. Klockmann U., Deppert W. Acylation: a new post-translational modification specific for plasma membrane-associated simian virus 40 large T-antigen. FEBS Lett. 1983, 151:257-259.
89. Ko L.J., Prives C. P53: puzzle and paradigm. Genes Dev. 1996, 10:1054-1072.
90. Korman B.D., Tyler K.L., Korman N.J. Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists. Arch. Dermatol. 2009, 145:937-942.
91. Krynska B., Otte J., Franks R., Khalili K., Croul S. Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals. Oncogene 1999, 18:39-46.
92. Kuhn C., Muller F., Melle C., Nasheuer H.P., Janus F., Deppert W., Grosse F. Surface plasmon resonance measurements reveal stable complex formation between p53 and DNA polymerase alpha. Oncogene 1999, 18:769-774.
93. Kuypers D.R. Management of polyomavirus-associated nephropathy in renal transplant recipients. Nat. Rev. Nephrol. 2012, 8:390-402.
94. Kuypers D.R., Vandooren A.K., Lerut E., Evenepoel P., Claes K., Snoeck R., Naesens L., Vanrenterghem Y. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am. J. Transplant. 2005, 5:1997-2004.
95. Kuypers D.R., Bammens B., Claes K., Evenepoel P., Lerut E., Vanrenterghem Y. A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients. J. Antimicrob. Chemother. 2009, 63:417-419.
96. Lane D.P. Cancer. p53, guardian of the genome. Nature 1992, 358:15-16.
97. Lavia P., Mileo A.M., Giordano A., Paggi M.G. Emerging roles of DNA tumor viruses in cell proliferation: new insights into genomic instability. Oncogene 2003, 22:6508-6516.
98. Lebeau I., Andrei G., Krecmerova M., De Clercq E., Holy A., Snoeck R. Inhibitory activities of three classes of acyclic nucleoside phosphonates against murine polyomavirus and primate simian virus 40 strains. Antimicrob. Agents Chemother. 2007, 51:2268-2273.
99. Lee J.O., Russo A.A., Pavletich N.P. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 1998, 391:859-865.
100. Lee J.S., Frederiksen P., Kossard S. Progressive Trichodysplasia spinulosa in a patient with chronic lymphocytic leukaemia in remission. Australas. J. Dermatol. 2008, 49:57-60.
101. Leung A.Y., Yuen K.Y., Kwong Y.L. Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm. Bone Marrow Transplant. 2005, 36:929-937.
102. Levine A.J. The common mechanisms of transformation by the small DNA tumor viruses: The inactivation of tumor suppressor gene products: p53. Virology 2009, 384:285-293.
103. Levine A.J., Momand J., Finlay C.A. The p53 tumour suppressor gene. Nature 1991, 351:453-456.
104. Li D., Zhao R., Lilyestrom W., Gai D., Zhang R., DeCaprio J.A., Fanning E., Jochimiak A., Szakonyi G., Chen X.S. Structure of the replicative helicase of the oncoprotein SV40 large tumour antigen. Nature 2003, 423:512-518.
105. Lilyestrom W., Klein M.G., Zhang R., Joachimiak A., Chen X.S. Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor. Genes Dev. 2006, 20:2373-2382.
106. Lin F., Zheng M., Li H., Zheng C., Li X., Rao G., Zheng M., Wu F., Zeng A. WU polyomavirus in children with acute lower respiratory tract infections. China. J. Clin. Virol. 2008, 42:94-102.
107. Lundberg A.S., Weinberg R.A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell Biol. 1998, 18:753-761.
108. Major E.O. Reemergence of PML in natalizumab-treated patients-new cases, same concerns. N. Engl. J. Med. 2009, 361:1041-1043.
109. Major E.O. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu. Rev. Med. 2010, 61:35-47.
110. Martel-Jantin C., Filippone C., Cassar O., Peter M., Tomasic G., Vielh P., Briere J., Petrella T., Aubriot-Lorton M.H., Mortier L., Jouvion G., Sastre-Garau X., Robert C., Gessain A. Genetic variability and integration of Merkel cell polyomavirus in Merkel cell carcinoma. Virology 2012, 426:134-142.
111. Matthews M.R., Wang R.C., Reddick R.L., Saldivar V.A., Browning J.C. Viral-associated Trichodysplasia spinulosa: a case with electron microscopic and molecular detection of the trichodysplasia spinulosa-associated human polyomavirus. J. Cutan. Pathol. 2011, 38:420-431.
112. Medina L., Grove K., Haltiwanger R.S. SV40 large T antigen is modified with O-linked N-acetylglucosamine but not with other forms of glycosylation. Glycobiology 1998, 8:383-391.
113. Meinke G., Phelan P., Moine S., Bochkareva E., Bochkarev A., Bullock P.A., Bohm A. The crystal structure of the SV40 T-antigen origin binding domain in complex with DNA. PLoS. Biol. 2007, 5:e23.
114. Meinke G., Phelan P., Fradet-Turcotte A., Archambault J., Bullock P.A. Structure-based design of a disulfide-linked oligomeric form of the simian virus 40 (SV40) large T antigen DNA-binding domain. Acta Crystallogr. D. Biol. Crystallogr. 2011, 67:560-567.
115. Meinke G., Phelan P.J., Fradet-Turcotte A., Bohm A., Archambault J., Bullock P.A. Structure-based analysis of the interaction between the simian virus 40 T-antigen origin binding domain and single-stranded DNA. J. Virol. 2011, 85:818-827.
116. Mendoza S.M., Konishi T., Miller C.W. Integration of SV40 in human osteosarcoma DNA. Oncogene 1998, 17:2457-2462.
117. Miller M.A., Weibel C., Ferguson D., Landry M.L., Kahn J.S. WU polyomavirus in patients infected with HIV or hepatitis C virus, Connecticut, USA, 2007. Emerg. Infect. Dis. 2009, 15:1095-1097.
118. Mitteldorf C., Mertz K.D., Fernandez-Figueras M.T., Schmid M., Tronnier M., Kempf W. Detection of Merkel cell polyomavirus and human papillomaviruses in Merkel cell carcinoma combined with squamous cell carcinoma in immunocompetent European patients. Am. J. Dermatopathol. 2012, 34:506-510.
119. Moens U., Ludvigsen M., Van Ghelue M. Human polyomaviruses in skin diseases. Patholog. Res. Int. 2011, 2011:123491.
120. Mohr I.J., Clark R., Sun S., Androphy E.J., MacPherson P., Botchan M.R. Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science 1990, 250:1694-1699.
121. Mungre S., Enderle K., Turk B., Porras A., Wu Y.Q., Mumby M.C., Rundell K. Mutations which affect the inhibition of protein phosphatase 2A by simian virus 40 small-t antigen in vitro decrease viral transformation. J. Virol. 1994, 68:1675-1681.
122. Murray-Zmijewski F., Lane D.P., Bourdon J.C. P53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death. Differ. 2006, 13:962-972.
123. Mutti L., Carbone M., Giordano G.G., Giordano A. Simian virus 40 and human cancer. Monaldi Arch. Chest Dis. 1998, 53:198-201.
124. Naess H., Glad S., Storstein A., Rinaldo C.H., Mork S.J., Myhr K.M., Hirsch H. Progressive multifocal leucoencephalopathy in an immunocompetent patient with favourable outcome. A case report. BMC Neurol. 2010, 10:32.
125. Nomine Y., Masson M., Charbonnier S., Zanier K., Ristriani T., Deryckere F., Sibler A.P., Desplancq D., Atkinson R.A., Weiss E., Orfanoudakis G., Kieffer B., Trave G. Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis. Mol. Cell 2006, 21:665-678.
126. Padgett B.L., Walker D.L., ZuRhein G.M., Eckroade R.J., Dessel B.H. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971, 1:1257-1260.
127. Pahari A., Rees L. BK virus-associated renal problems-clinical implications. Pediatr. Nephrol. 2003, 18:743-748.
128. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 2006, 118:3030-3044.
129. Pipas J.M. SV40: cell transformation and tumorigenesis. Virology 2009, 384:294-303.
130. Poulin D.L., DeCaprio J.A. The carboxyl-terminal domain of large T antigen rescues SV40 host range activity in trans independent of acetylation. Virology 2006, 349:212-221.
131. Poulin D.L., Kung A.L., DeCaprio J.A. P53 targets simian virus 40 large T antigen for acetylation by CBP. J. Virol. 2004, 78:8245-8253.
132. Ramos E., Drachenberg C.B., Portocarrero M., Wali R., Klassen D.K., Fink J.C., Farney A., Hirsch H., Papadimitriou J.C., Cangro C.B., Weir M.R., Bartlett S.T. BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program. Clin. Transpl. 2002, 143-153.
133. Rao S., Garcea R.L., Robinson C.C., Simoes E.A. WU and KI polyomavirus infections in pediatric hematology/oncology patients with acute respiratory tract illness. J. Clin. Virol. 2011, 52:28-32.
134. Razonable R.R., Aksamit A.J., Wright A.J., Wilson J.W. Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy. Mayo Clin. Proc. 2001, 76:1171-1175.
135. Rivlin N., Brosh R., Oren M., Rotter V. Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis. Genes Cancer 2011, 2:466-474.
136. Ryschkewitsch C.F., Jensen P.N., Monaco M.C., Major E.O. JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab. Ann. Neurol. 2010, 68:384-391.
137. Sadler G.M., Halbert A.R., Smith N., Rogers M. Trichodysplasia spinulosa associated with chemotherapy for acute lymphocytic leukaemia. Australas. J. Dermatol. 2007, 48:110-114.
138. Sanders C.M., Kovalevskiy O.V., Sizov D., Lebedev A.A., Isupov M.N., Antson A.A. Papillomavirus E1 helicase assembly maintains an asymmetric state in the absence of DNA and nucleotide cofactors. Nucleic Acids Res. 2007, 35:6451-6457.
139. Santucci S., Bonne-Andrea C., Clertant P. Bovine papillomavirus type 1 E1 ATPase activity does not depend on binding to DNA nor to viral E2 protein. J. Gen. Virol. 1995, 76(Pt 5):1129-1140.
140. Saraste M., Sibbald P.R., Wittinghofer A. The P-loop-a common motif in ATP- and GTP-binding proteins. Trends Biochem. Sci. 1990, 15:430-434.
141. Sauvage V., Foulongne V., Cheval J., Ar Gouilh.M., Pariente K., Dereure O., Manuguerra J.C., Richardson J., Lecuit M., Burguiere A., Caro V., Eloit M. Human polyomavirus related to African green monkey lymphotropic polyomavirus. Emerg. Infect. Dis. 2011, 17:1364-1370.
142. Scheidtmann K.H. Phosphorylation of simian virus 40 large T antigen: cytoplasmic and nuclear phophorylation sites differ in their metabolic stability. Virology 1986, 150:85-95.
143. Scheidtmann K.H., Mumby M.C., Rundell K., Walter G. Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen. Mol. Cell Biol. 1991, 11:1996-2003.
144. Schneider J., Fanning E. Mutations in the phosphorylation sites of simian virus 40 (SV40) T antigen alter its origin DNA-binding specificity for sites I or II and affect SV40 DNA replication activity. J. Virol. 1988, 62:1598-1605.
145. Schowalter R.M., Pastrana D.V., Pumphrey K.A., Moyer A.L., Buck C.B. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host. Microbe 2010, 7:509-515.
146. Schrama D., Ugurel S., Becker J.C. Merkel cell carcinoma: recent insights and new treatment options. Curr. Opin. Oncol. 2012, 24:141-149.
147. Scuda N., Hofmann J., Calvignac-Spencer S., Ruprecht K., Liman P., Kuhn J., Hengel H., Ehlers B. A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus. J. Virol. 2011, 85:4586-4590.
148. Sedman J., Stenlund A. Co-operative interaction between the initiator E1 and the transcriptional activator E2 is required for replicator specific DNA replication of bovine papillomavirus in vivo and in vitro. EMBO J. 1995, 14:6218-6228.
149. Seguin S.P., Evans C.W., Nebane-Akah M., McKellip S., Ananthan S., Tower N.A., Sosa M., Rasmussen L., White E.L., Maki B.E., Matharu D.S., Golden J.E., Aube J., Brodsky J.L., Noah J.W. High-throughput screening identifies a bisphenol inhibitor of SV40 large T antigen ATPase activity. J. Biomol. Screen. 2012, 17:194-203.
150. Seguin S.P., Ireland A.W., Gupta T., Wright C.M., Miyata Y., Wipf P., Pipas J.M., Gestwicki J.E., Brodsky J.L. A screen for modulators of large T antigen's ATPase activity uncovers novel inhibitors of simian virus 40 and BK virus replication. Antiviral Res. 2012, 96:70-81.
151. Shah K.V. Search for SV40 in human mesotheliomas. Dev. Biol. Stand. 1998, 94:67-68.
152. Shah K.V. Does SV40 infection contribute to the development of human cancers?. Rev. Med. Virol. 2000, 10:31-43.
153. Shah K.V. SV40 and human cancer: a review of recent data. Int. J. Cancer 2007, 120:215-223.
154. Shah K.V., Daniel R.W., Strandberg J.D. Sarcoma in a hamster inoculated with BK virus, a human papovavirus. J. Natl. Cancer Inst. 1975, 54:945-950.
155. Sharma B.N., Li R., Bernhoff E., Gutteberg T.J., Rinaldo C.H. Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells. Antiviral Res. 2011, 92:115-123.
156. Shimazu T., Komatsu Y., Nakayama K.I., Fukazawa H., Horinouchi S., Yoshida M. Regulation of SV40 large T-antigen stability by reversible acetylation. Oncogene 2006, 25:7391-7400.
157. Shuda M., Feng H., Kwun H.J., Rosen S.T., Gjoerup O., Moore P.S., Chang Y. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc. Natl. Acad. Sci. USA 2008, 105:16272-16277.
158. Shuda M., Kwun H.J., Feng H., Chang Y., Moore P.S. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J. Clin. Invest 2011, 121:3623-3634.
159. Siebrasse E.A., Reyes A., Lim E.S., Zhao G., Mkakosya R.S., Manary M.J., Gordon J.I., Wang D. Identification of MW polyomavirus, a novel polyomavirus in human stool. J. Virol. 2012, 86:10321-10326.
160. Smelkova N.V., Borowiec J.A. Dimerization of simian virus 40 T-antigen hexamers activates T-antigen DNA helicase activity. J. Virol. 1997, 71:8766-8773.
161. Sol C.J., van der Noordaa J. Oncogenicity of SV40 DNA in the Syrian Hamster. J. Gen. Virol. 1977, 37:635-638.
162. Sontag E. Protein phosphatase 2A: the Trojan Horse of cellular signaling. Cell Signal. 2001, 13:7-16.
163. Sontag J.M., Sontag E. Regulation of cell adhesion by PP2A and SV40 small tumor antigen: an important link to cell transformation. Cell Mol. Life Sci. 2006, 63:2979-2991.
164. Sontag E., Fedorov S., Kamibayashi C., Robbins D., Cobb M., Mumby M. The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation. Cell 1993, 75:887-897.
165. Sullivan C.S., Cantalupo P., Pipas J.M. The molecular chaperone activity of simian virus 40 large T antigen is required to disrupt Rb-E2F family complexes by an ATP-dependent mechanism. Mol. Cell Biol. 2000, 20:6233-6243.
166. Sullivan C.S., Baker A.E., Pipas J.M. Simian virus 40 infection disrupts p130-E2F and p107-E2F complexes but does not perturb pRb-E2F complexes. Virology 2004, 320:218-228.
167. Swenson J.J., Frisque R.J. Biochemical characterization and localization of JC virus large T antigen phosphorylation domains. Virology 1995, 212:295-308.
168. Swenson J.J., Trowbridge P.W., Frisque R.J. Replication activity of JC virus large T antigen phosphorylation and zinc finger domain mutants. J. Neurovirol. 1996, 2:78-86.
169. Takemoto K.K., Segawa K. A new monkey lymphotropic papovavirus: characterization of the virus and evidence of a related virus in humans. Prog. Clin. Biol. Res. 1983, 105:87-96.
170. Talis A.L., Huibregtse J.M., Howley P.M. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J. Biol. Chem. 1998, 273:6439-6445.
171. Tan B.H., Busam K.J. Virus-associated Trichodysplasia spinulosa. Adv. Anat. Pathol. 2011, 18:450-453.
172. Teramoto S., Kaiho M., Takano Y., Endo R., Kikuta H., Sawa H., Ariga T., Ishiguro N. Detection of KI polyomavirus and WU polyomavirus DNA by real-time polymerase chain reaction in nasopharyngeal swabs and in normal lung and lung adenocarcinoma tissues. Microbiol. Immunol. 2011, 55:525-530.
173. Teramoto S., Koseki N., Yoshioka M., Matsunami Y., Yanazume N., Nawate M., Shikano T., Takahashi Y., Kikuta H., Ishiguro N. WU polyomavirus infection confirmed by genetic and serologic tests in an infant with Bronchitis. Pediatr. Infect. Dis. J. 2011, 30:918.
174. Testa J.R., Giordano A. SV40 and cell cycle perturbations in malignant mesothelioma. Semin. Cancer Biol. 2001, 11:31-38.
175. Tommasino M., Crawford L. Human papillomavirus E6 and E7: proteins which deregulate the cell cycle. Bioessays 1995, 17:509-518.
176. Topalis D., Lebeau I., Krecmerova M., Andrei G., Snoeck R. Activities of different classes of acyclic nucleoside phosphonates against BK virus in primary human renal cells. Antimicrob. Agents Chemother. 2011, 55:1961-1967.
177. Trusch F., Klein M., Finsterbusch T., Kuhn J., Hofmann J., Ehlers B. Seroprevalence of human polyomavirus 9 and cross-reactivity to African green monkey-derived lymphotropic polyomavirus. J. Gen. Virol. 2012, 93:698-705.
178. Tsai J., Douglas M.G. A conserved HPD sequence of the J-domain is necessary for YDJ1 stimulation of Hsp70 ATPase activity at a site distinct from substrate binding. J. Biol. Chem. 1996, 271:9347-9354.
179. Valle M., Gruss C., Halmer L., Carazo J.M., Donate L.E. Large T-antigen double hexamers imaged at the simian virus 40 origin of replication. Mol. Cell Biol. 2000, 20:34-41.
180. van der Meijden E., Janssens R.W., Lauber C., Bouwes Bavinck J.N., Gorbalenya A.E., Feltkamp M.C. Discovery of a new human polyomavirus associated with Trichodysplasia spinulosa in an immunocompromized patient. PLoS. Pathog. 2010, 6:e1001024.
181. van der Meijden E., Kazem S., Burgers M.M., Janssens R., Bouwes Bavinck J.N., de Melker H., Feltkamp M.C. Seroprevalence of Trichodysplasia spinulosa-associated polyomavirus. Emerg. Infect. Dis. 2011, 17:1355-1363.
182. Viscidi R.P., Clayman B. Serological cross reactivity between polyomavirus capsids. Adv. Exp. Med. Biol. 2006, 577:73-84.
183. Vousden K.H. Regulation of the cell cycle by viral oncoproteins. Semin. Cancer Biol. 1995, 6:109-116.
184. Weiner B.M., Bradley M.K. Specific mutation of a regulatory site within the ATP-binding region of simian virus 40 large T antigen. J. Virol. 1991, 65:4973-4984.
185. Werness B.A., Levine A.J., Howley P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990, 248:76-79.
186. Wessel R., Schweizer J., Stahl H. Simian virus 40 T-antigen DNA helicase is a hexamer which forms a binary complex during bidirectional unwinding from the viral origin of DNA replication. J. Virol. 1992, 66:804-815.
187. White P.W., Pelletier A., Brault K., Titolo S., Welchner E., Thauvette L., Fazekas M., Cordingley M.G., Archambault J. Characterization of recombinant HPV6 and 11 E1 helicases: effect of ATP on the interaction of E1 with E2 and mapping of a minimal helicase domain. J. Biol. Chem. 2001, 276:22426-22438.
188. White P.W., Faucher A.M., Massariol M.J., Welchner E., Rancourt J., Cartier M., Archambault J. Biphenylsulfonacetic acid inhibitors of the human papillomavirus type 6 E1 helicase inhibit ATP hydrolysis by an allosteric mechanism involving tyrosine 486. Antimicrob. Agents Chemother. 2005, 49:4834-4842.
189. White E.A., Sowa M.E., Tan M.J., Jeudy S., Hayes S.D., Santha S., Munger K., Harper J.W., Howley P.M. Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses. Proc. Natl. Acad. Sci. USA 2012, 109:E260-E267.
190. Wiseman A.C. Polyomavirus nephropathy: a current perspective and clinical considerations. Am. J. Kidney Dis. 2009, 54:131-142.
191. Wright C.M., Seguin S.P., Fewell S.W., Zhang H., Ishwad C., Vats A., Lingwood C.A., Wipf P., Fanning E., Pipas J.M., Brodsky J.L. Inhibition of Simian Virus 40 replication by targeting the molecular chaperone function and ATPase activity of T antigen. Virus Res. 2009, 141:71-80.
192. Xie A.Y., Bermudez V.P., Folk W.R. Stimulation of DNA replication from the polyomavirus origin by PCAF and GCN5 acetyltransferases: acetylation of large T antigen. Mol. Cell Biol. 2002, 22:7907-7918.
193. Yang L., Li R., Mohr I.J., Clark R., Botchan M.R. Activation of BPV-1 replication in vitro by the transcription factor E2. Nature 1991, 353:628-632.
194. Yu J., Boyapati A., Rundell K. Critical role for SV40 small-t antigen in human cell transformation. Virology 2001, 290:192-198.
195. Zerrahn J., Knippschild U., Winkler T., Deppert W. Independent expression of the transforming amino-terminal domain of SV40 large I antigen from an alternatively spliced third SV40 early mRNA. EMBO J. 1993, 12:4739-4746.
196. Zhen H.N., Zhang X., Bu X.Y., Zhang Z.W., Huang W.J., Zhang P., Liang J.W., Wang X.L. Expression of the simian virus 40 large tumor antigen (Tag) and formation of Tag-p53 and Tag-pRb complexes in human brain tumors. Cancer 1999, 86:2124-2132.
197. Zhen H., Zhang X., Zhang Z., Fei Z., He X., Liang J., Huang W., Liu X., Zhang P. Simian virus 40 large tumor antigen forms specific complexes with p53 and pRb in human brain tumors. Chin Med. J. (Engl.) 2001, 114:382-386.
198. Zhuang W.L., Lu X.D., Lin G.Y., Wu Y., Lin C.X., Chen P.Z., Xie S.X., Zhang N., Ma L. WU polyomavirus infection among children in South China. J. Med. Virol. 2011, 83:1440-1445.
199. zur Hausen H., de Villiers E.M. Human papillomaviruses. Annu. Rev. Microbiol. 1994, 48:427-447.
200. zur Hausen H., Gissmann L. Lymphotropic papovaviruses isolated from African green monkey and human cells. Med. Microbiol. Immunol. 1979, 167:137-153.